Publications of Edgar Meinl
All genres
Journal Article (58)
2012
Journal Article
209 (3), pp. 521 - 535 (2012)
Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. Journal of Experimental Medicine
Journal Article
25 (3), pp. 231 - 238 (2012)
Identifying autoantigens in demyelinating diseases: Valuable clues to diagnosis and treatment? Current Opinion in Neurology
Journal Article
22, pp. 607 - 618 (2012)
Prospects of transcript profiling for mRNAs and microRNAs using formalin fixed and paraffin embedded dissected autoptic multiple sclerosis lesions. Brain Pathology
Journal Article
22 (5), pp. 607 - 618 (2012)
Prospects of transcript profiling for mRNAs and microRNAs using formalin-fixed and paraffin-embedded dissected autoptic multiple sclerosis lesions. Brain Pathology
Journal Article
135, pp. 1819 - 1833 (2012)
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain
Journal Article
8 (11), pp. 613 - 623 (2012)
B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nature Reviews Neurology
Journal Article
319 (1-2), pp. 2 - 7 (2012)
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis. JOURNAL OF THE NEUROLOGICAL SCIENCES
Journal Article
5 (3), pp. 147 - 159 (2012)
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more. Therapeutic Advances in Neurological Disorders
Journal Article
79 (22), pp. 2162 - 2163 (2012)
MicroRNAs in the CSF Macro-advance in MS? Neurology
Journal Article
79 (23), pp. 2241 - 2248 (2012)
Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 2011
Journal Article
85 (19), pp. 9680 - 9685 (2011)
Expression of herpes simplex virus 1-encoded microRNAs in human trigeminal ganglia and their relation to local T-cell infiltrates. Journal of Virology
Journal Article
7 (1), pp. 56 - 59 (2011)
The emerging role of microRNAs in multiple sclerosis. Nature Reviews Neurology
Journal Article
311 (Suppl. 1), pp. S12 - S15 (2011)
Untapped targets in multiple sclerosis. Journal of the Neurological Sciences
Journal Article
306 (1-2), pp. 180 - 182 (2011)
Humoral autoimmunity in multiple sclerosis. Journal of the Neurological Sciences
Journal Article
76 (15), pp. 1310 - 1315 (2011)
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology
Journal Article
77 (6), pp. 580 - 588 (2011)
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2010
Journal Article
88 (8), pp. 753 - 761 (2010)
Axo-glial antigens as targets in multiple sclerosis: Implications for axonal and grey matter injury. Journal of Molecular Medicine
Journal Article
1 (2), pp. 47 - 60 (2010)
Identifying targets for autoantibodies in CNS inflammation: Strategies and achievements. Clinical and Experimental Neuroimmunology
Journal Article
20 (5), pp. 966 - 975 (2010)
Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells. Brain Pathology 2009
Journal Article
106 (20), pp. 8302 - 8307 (2009)
Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proceedings of the National Academy of Sciences of the United States of America